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Abstract 
Studies examining risk factors associated with vasovagal reactions (VVRs) during autologous blood donations, 
especially in younger subjects, have been limited. The aim of the present study was to define risk factors for 
VVRs during preoperative autologous blood donation in patients, including those younger than 18 years old. We 
retrospectively analyzed 4,192 autologous, preoperative blood donations between 2007 and 2015 at Okayama 
University Hospital. Eighty-seven (2.08%) of the patients experienced VVRs. VVRs occurred approximately 
three times as often in patients 0–17 years old (16/320, 5.0%) than in patients 18 years and older (71/3,872, 
1.8%). In particular, VVRs occurred more frequently in those 10–13 years old, and decreased with older age (P 
= 0.006). In a univariate analysis, younger age, lower body mass index, lower systolic blood pressure, lower 
body weight, lower total blood volume, female gender, first-time collection, and higher heart rate were 
associated with a higher incidence of VVRs. In a multivariate analysis, lower systolic blood pressure (P < 
0.001), higher heart rate (P = 0.007), and first-time collection (P = 0.015), remained independent predictors of 
VVRs. These results emphasize the need for careful attention during blood collection. 
Keywords: Autologous blood donation, vasovagal reactions 
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Introduciton 
Autologous blood donation is widely used for preoperative blood preparation to reduce exposure to allogeneic 
blood[1]. Autologous and allogeneic blood donors occasionally experience adverse reactions during or after 
blood withdrawal, such as weakness, pallor, nausea, sweating, and fainting [2, 3]. These symptoms are generally 
called “vasovagal reactions” (VVRs)[2, 4]. However, the pathophysiology of VVRs is not yet completely 
understood[5]. Although risk factors for VVRs have been analyzed mainly in healthy allogeneic donors or 
peripheral blood stem cell donors [2, 4, 6-8], reports describing patients undergoing autologous collection have 
been limited. In particular, there are few data concerning patients younger than 16–18 years old. In the present 
study, we analyzed the risk factors for VVRs during autologous donation in patients, including those younger 
than 18 years old, at a single institution. 
Materials and methods 
We retrospectively collected medical information from 4,192 patients (groups I + II) who underwent autologous 
preoperative blood collection between July 2007 and June 2010 (group I, n = 1,649) and between July 2010 and 
June 2015 (groups II, n = 2543) at Okayama University Hospital in Okayama City, Japan. The study protocol 
was approved by the Institutional Review Board of Okayama University Hospital and complied with the 
provisions of the Declaration of Helsinki. 
Patients were screened for vital signs, height, body weight, and complete blood count. Enrolled patients 
underwent whole blood phlebotomy in a designated room: blood volumes did not exceed 400 mL, or [body 
weight]/50 × 400 mL if the patient’s body weight was less than 50 kg. All collections were conducted by a 
physician and nurse from the Department of Transfusion Medicine at Okayama University Hospital. An 
18-gauge needle was inserted into an antecubital vein or a large forearm vein of each patient, and autologous 
blood was collected using a negative pressure blood drawing device (Hemoquick; Terumo, Tokyo, Japan). After 
phlebotomy, the patients were administered an intravenous infusion of saline, or consumed at least 400 mL of 
fluid for volume replacement. Most patients were scheduled for collection two or three times with 7-day 
intervals. The last collection was performed 3 or more days before the operation. In our protocol, the following 
exclusion criteria were applied: (1) a hemoglobin (Hb) level of < 10 g/dL (patients with 10–11 g/dL were 
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included only when their baseline Hb level was 10–11 g/dL), (2) systolic blood pressure > 200 mmHg, or < 90 
mmHg, (3) diastolic blood pressure > 120 mmHg or < 50 mmHg, (4) unstable angina pectoris, recent 
myocardial infarction (within the previous 6 months), severe aortic stenosis, or severe dysrhythmia, (5) ongoing 
bacterial infection, (6) unmanageable diabetes, and (7) a history of uncontrolled convulsions. Body mass index 
(BMI) for each patient was calculated based on weight and height. Similarly, total blood volume (TBV) was 
calculated from the height and weight using gender-specific formulas from Nadler and colleagues [9]. 
All VVRs were recorded by the staff of the Department of Transfusion Medicine on a specifically designed form. 
VVRs were divided into mild [pallor, weakness, dizziness, sweating, nausea accompanied by bradycardia (> 40 
beats/min; bpm), or hypotension (> 90 mmHg) decreased by more than 20 mmHg compared to pre-donation], 
moderate [unconsciousness, vomiting, bradycardia (≤ 40 bpm), or hypotension (≤ 90 mmHg) in addition to mild 
symptoms], and severe (convulsion, tetany, or incontinence in addition to moderate symptoms) [10]. 
Statistics 
The basic characteristics of each group (non-VVR and VVR) were compared using the χ2 test or Student’s t-test, 
as appropriate. First, we analyzed group I, and then the differences in relation to group II and the overall group 
(groups I + II). Multivariate analyses were performed using a logistic regression model to define the 
independent impact of each variable on VVR incidence. Statistical tests were two-sided, and the differences 
were deemed to be statistically significant if p < 0.05. Linear regression analysis was used to determine the 
correlation between age and susceptibility to VVRs; R > 0.7 was considered to as a strong correlation while a p 
< 0.05 was considered statistically significant. Data were analyzed using STATA software (ver. 12; StataCorp, 
College Station, TX, USA). 
Results 
During the study period, 4,192 autologous whole blood donations were made. Group I was comprised of 1,649 
patients who donated between July 2007 and June 2010, and group II was comprised of 2,543 patients who 
donated between July 2010 and June 2015. Table 1 shows the patient background data. Most of the patients were 
females, and were being treated for orthopedic or gynecological diseases. The median patient age was 54 (range 
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4–86) years. This study included 319 young patients ranging in age from 0 to 17 years. There were 44 VVRs 
(2.67%) in group I, 43 VVRs (1.69%) in group II, and 87 VVRs (2.08%) in groups I + II. Place, time and 
description of blood donation for the patients did not differ between groups I and II. However, the doctors and 
staff differed between groups I and II. Doctors’ skill and the accumulation of staff knowledge or experience 
might partly influence the occurrence of VVRs. 
Severe, moderate, and mild VVRs were observed in six (6.9%), two (2.3%), and 79 (90.8%) patients, 
respectively. Figure 1 shows the distributions of each VVR event grade by age. There was no increased 
susceptibility to severe VVRs with age. Figure 2 shows the VVR incidence rate by age. The VVR rate of 
0–17-year-old patients was approximately three times as high as that of patients 18–89 years old (p < 0.001). 
Among the younger populations, the VVR rate of 10–13-year-old patients was the highest (5/92, 5.43%), 
followed by 14–17-year-olds (11/203, 5.41%), and 18-19 year-olds (3/72, 4.17%). However, there were no 
VVRs in patients under 10 years old. In the adult population, VVR susceptibility was significantly negatively 
correlated with increasing age (20–29 years, 5.0%; 30–39 years, 4.0%; 40–49 years, 1.6%; 50–59 years, 1.4%; 
60–69 years, 0.8%; and 70–79 years, 0.5%; R = 0.88, p = 0.006). 
Table 2 lists the characteristics of VVR and non-VVR patients. Univariate analyses revealed that younger age, 
lower BMI, lower pre-collection systolic blood pressure, lower body weight, lower TBV, female gender, 
first-time collection, and higher heart rates were associated with a significantly higher incidence of VVRs in 
group I. In group II, younger age, and lower pre-collection systolic blood pressure were the significant factors 
associated with VVRs. In the overall group, all of these factors except female gender remained associated with a 
higher incidence of VVRs. 
To determine which variables were independent predictors of VVRs, a logistic regression analysis was 
performed using seven predictors (Table 3). In group I, First-time collection (odds ratio (OR) = 2.76, 95% CI = 
1.31-5.81, p = 0.007), younger age (< 18 years old: OR = 2.77, 95% CI = 1.16-6.61, p = 0.021), higher heart rate 
(˃ 74 bpm: OR = 2.15, 95% CI = 1.06-4.38, p = 0.035), and lower pre-collection systolic blood pressure (< 120 
mmHg: OR = 2.17, 95% CI = 1.05-4.49, p = 0.037) were significant independent predictors of VVRs. In group 
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II, lower systolic blood pressure (OR = 4.23, 95% CI = 2.04-8.76, p < 0.001) was the only significant 
independent predictor of VVRs. In the overall group, lower systolic blood pressure (OR = 2.45, 95% CI = 
1.50–4.01, p < 0.001), higher heart rate (OR = 1.92, 95% CI = 1.20–3.09, p = 0.007), and first-time collection 
(OR = 1.81, 95% CI = 1.12–2.92, p = 0.015) remained significant predictors of VVRs. The populations in the 
overall group were larger than in group I and group II; therefore, the rates of VVRs and the independent 
predictors of VVRs in this study might reflect the true situation in the overall group. 
Discussion 
An important aim of this study was to assess the risk for VVRs in younger patients in particular, because their 
life expectancy is long, and thus they may obtain greater benefit from autologous blood transfusions than 
allogeneic blood transfusions. In this study, we included younger patients (4–9 years old: n = 25, 10–17 years 
old: n = 295) than previous studies[11-16]. Some reports did not assess donors under 17 years of age, because 
they primarily analyzed allogeneic donors[2, 4, 6, 7]. Previous studies demonstrated the safety of autologous 
blood donation for pediatric cardiac surgery (n = 80)[13] and homologous donation from high school 
students[17], and the risk of VVR was reported to be higher in younger autologous or homologous blood 
donors[2, 3, 11, 15]. Our data revealed that the patients most susceptible to developing VVR were 10–13 years 
old, followed by those aged 14–17 years. Eder et al. reported that 16- and 17-year-olds were significantly more 
likely to experience a loss of consciousness and major systemic (syncopal-type) complications (0.53%) than 18- 
and 19-year-old donors (0.33%), or donors aged 20 years or older (0.08%) during allogeneic donation [18]. Our 
data add evidence that patients younger than 14 years of age are yet more susceptible to develop VVRs. 
Moreover, susceptibility to VVRs decreased significantly according to older age. However, there was no case of 
VVR under the age of 10 years, although we could not discuss this statistically because there were only 25 
patients. 
One possible reason that younger patients are at higher risk of VVRs is the relationship between ventricular 
baroreceptor sensitivity and age[2, 19]. Healthy, young patients have lower ventricular baroreceptor sensitivity 
when subjected to physical or psychological stress[2]. Carotid-aortic baroreceptor sensitivity, which correlates 
inversely with ventricular baroreceptor sensitivity, decreases with age[20]. This downregulates ventricular 
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baroreceptor sensitivity in younger patients, possibly resulting in their higher risk of VVRs[2]. 
VVRs occur after overstimulation of the parasympathetic versus sympathetic nervous system [5]. These nervous 
systems may be affected by the patient’s emotions. In fact, VVRs are mediated by emotions [21]. Moreover, it 
was reported that psychological stress suppressed ventricular baroreceptor sensitivity[22]; thus, nervous patients 
may be more susceptible to VVRs[4]. It is expected that patients who donate autologous blood for the first time 
would be more anxious than those who give repeat blood donations, simply because the procedure of blood 
donation is unknown to them. Higher heart rate might also correlate with patient stress or anxiety and thereby be 
a risk factor for VVRs. 
In this study, pre-collection systolic blood pressure < 120 mmHg was shown to be the most significant risk 
factor of VVRs. Ogata et al. demonstrated that lower diastolic blood pressure was associated with a higher VVR 
rate, explaining why younger donors have lower blood pressure [23]. However, there is a report showing that a 
lower systolic blood pressure of < 100 mmHg was associated with a significantly lower VVR rate [24]. This 
discrepancy could be explained by the method of multivariate analysis; i.e., adjusted or not adjusted for factors 
including age [23, 24]. In our analyses, the OR and p-value were 2.17 (95% CI = 1.05–4.49) and 0.037, 
respectively, in group I. In group II, lower systolic blood pressure revealed the only significant independent 
predictor of VVRs (OR = 4.23, 95% CI = 2.04-8.76, p < 0.001). The additional analysis that included more 
patients (the overall group) revealed that lower systolic blood pressure was the strongest independent predictor 
of VVR (OR = 2.45 (95% CI = 1.50–4.01), p < 0.001)). Our data add evidence that patients with a lower blood 
pressure are more susceptible to VVRs. 
The high risk groups for VVRs are generally reported to be young, female, first-time donors [2, 18, 25-27]. In 
our analysis, female gender was a significant risk factor in the univariate analysis in group I; however, it was not 
significant in the multivariate analysis in both group I and the overall group. This might be explained by the fact 
that more female patients were included in this study (females: 2,992, males: 1,200) compared with previous 
reports, resulting in less power to determine the susceptibility in males. 
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One limitation of this study was its retrospective nature. Also, the populations in each age group were not large; 
thus, the rates of VVRs in this study may not reflect the true situation. For example, that there were no VVRs in 
the group aged under 10 years may be because more attention was paid to these patients. However, these data 
may be valuable because the peak of the risk, in terms of age, cannot be seen in data on healthy allogeneic 
donors. 
In summary, risk factors for VVRs include lower systolic blood pressure, higher heart rate, and first-time 
collection. In younger population, the patients most susceptible to developing VVR were 10–13 years old, 
followed by those aged 14–17 years. Even in the adult patient population, younger age was correlated with 
susceptibility to VVRs. These data should provide both reassurance and caution to blood collection staff, 
patients, and physicians with regard to the safety and risks of autologous blood collection. It may be possible to 
prevent VVRs by diminishing the anxiety of autologous patients, especially among younger populations. 
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Figure legend 
Figure 1 
Distributions of mild, moderate, and severe vasovagal reactions (VVRs) by age in 4,192 autologous blood 
donations. 
Figure 2 
Incidence of VVRs by age. The VVR rate of 0–17-year-old patients was approximately three times as high as 
that of patients 18–89 years old (*: p < 0.001). The VVR rate of 10–13 year old patients was highest (5/92, 
5.43%), followed by 14–17-year-olds (11/203, 5.41%), and 18-19 year-olds (3/72, 4.17%). In the adult 
population, susceptibility to VVRs was correlated negatively with increasing age with statistical significance 
(20–29 years: 5.0%, 30–39 years: 4.0%, 40–49 years: 1.6%, 50–59 years: 1.4%, 60–69 years: 0.8%, and 70–79 
years: 0.5%, R = 0.88, p = 0.006). Error bars indicate 95% confidence intervals. 
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Table 1. Patient Characteristics 
Primary disease n (female/male) Median age (range) (years) 
Total 4,192 (2,995/1,197) 54 (4–86) 
Orthopedics 2,050 (1,618/432) 57 (4–86) 
Gynecology/Obstetrics 1,175 (1,175/0) 41 (18–76) 
Urology  532 (7/525) 67 (43–83) 
Cardiovascular surgery 247 (87/160) 53 (8–83) 
Dentistry  81 (48/33) 52 (16–52) 
Other 107 (60/47) 33.5 (8–77) 
Table
2 
Table 2. VVR predictors by univariate analysis 
Group I Group II The overall group (Groups I + II) 
Characteristic non-VVR VVR p value non-VVR VVR p value non-VVR VVR p value 
(n = 1,605) (n = 44) (n = 2,500) (n = 43) (n = 4,105) (n = 87) 
Age (years) 56 (4–84) 35 (11–82) < 0.0001 53 (5–86) 36 (10–74) < 0.0001 55 (4–86) 36 (10–82) < 0.0001 
BMI (kg/m2) 22.3 (13.5–44.0)  20.4 (15.1–26.1) < 0.0001 22.5 (10.2–48.7)  21.8 (14.0–30.0)  0.0928 22.4 (10.2–48.7)  21.3 (14.0–30.0)  0.0007 
Systolic BP (/mmHg) 135 (91–198) 120 (101–147) < 0.0001 124 (90–189) 110 (93–146) < 0.0001 128 (90–198) 117 (93–147) < 0.0001 
Weight (kg) 54.8 (11.5–103.7) 51.0 (21.1–72.0)  0.0002 56.0 (15.0–110.0) 55.0 (17.4–78.0)  0.0987 55.1 (11.5–110.0) 52.0 (17.4–78.0)  0.0016 
TBV (L) 3.38 (1.19–5.73)  3.22 (1.89–4.82)  0.008 3.85 (0.62–7.45)  3.76 (0.78–5.38)  0.1304 3.83 (0.62–7.45)  3.67 (0.78–5.38)  0.0115 
Male/female 468/1,137 6/38 0.025 715/1,785 11/32 0.664 1,183/2,922 17/70 0.058 
First time collection 867 (54.0 %) 31 (70.5 %) 0.031 1,472 (58.9 %) 28 (65.1 %) 0.410 2,339 (57.0 %) 59 (67.8 %) 0.043 
Pulse (/bpm) 74 (45–127) 79 (53–103) 0.039 74 (45–140) 81 (52–111) 0.9844 74 (45–140) 80 (52–111) 0.0019 
Height (cm) 157 (100–185) 158 (118.3–173.5) n.s. 
Diastolic BP (/mmHg) 84 (50–119) 82 (54–106) n.s. 
WBC count (/L) 5,950 (2,020–26,370) 61,10 (2,720–11,810) n.s. 
RBC count (106/L) 420 (214–816) 423 (349–552) n.s. 
Hemoglobin (g/dL) 12.8 (10.0–18.8)  12.7 (10.7–17.2) n.s. 
Hematocrit (%) 37.8 (27.7–62.3)  37.2 (29.4–48.9) n.s. 
Platelet count (/L) 27.4 (9.7–75) 26.1 (15.7–50.1) n.s. 
BMI, body mass index; TBV, total blood volume; BP, blood pressure; WBC, white blood cell; RBC, red blood cell; n.s., not significant. 
Data are presented as n (%) for male/female and first-time donation variables and as the median value (range) for all other variables. 
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Table 3. VVR predictors by multivariate analysis 
    Group I    Group II   The overall group (Groups I + II) 
Variable   OR (95% CI) p value  OR (95% CI)  p value  OR (95% CI) p value 
First-time collection  2.76 (1.31-5.81) 0.007  1.44 (0.76-2.72) 0.265  1.81 (1.12-2.92) 0.015 
Age (< 18 years old)  2.77 (1.16-6.61) 0.021  1.00 (0.36-2.74) 0.993  1.76 (0.92-3.34) 0.086 
Heart rate (˃ 74/min) 2.15 (1.06-4.38) 0.035  1.80 (0.95-3.41) 0.072  1.92 (1.20-3.09) 0.007 
Systolic BP (< 120 mmHg) 2.17 (1.05-4.49) 0.037  4.23 (2.04-8.76) < 0.001  2.45 (1.50-4.01) < 0.001 
Female gender  2.22 (0.72-6.86) 0.166  0.77 (0.36-1.67) 0.508  1.27 (0.68-2.36) 0.452 
Body mass index (< 22 kg/m2) 1.64 (0.74-3.66) 0.224  1.21 (0.61-2.43) 0.574  1.51 (0.90-2.53) 0.118 
Total blood volume (< 3.5 L) 0.70 (0.28-1.75) 0.448  0.67 (0.32-1.40) 0.291  0.72 (0.41-1.25) 0.242 
 
CI, confidence interval, OR, odds ratio. 
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